Akso Health Group Sponsored ADR (NASDAQ:AHG – Get Free Report) shares gapped up before the market opened on Friday . The stock had previously closed at $1.49, but opened at $1.56. Akso Health Group shares last traded at $1.54, with a volume of 228 shares changing hands.
Analysts Set New Price Targets
AHG has been the topic of several research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Akso Health Group in a research report on Monday, April 20th. Wall Street Zen raised shares of Akso Health Group to a “sell” rating in a research report on Saturday, May 2nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.
Read Our Latest Stock Analysis on AHG
Akso Health Group Price Performance
Institutional Investors Weigh In On Akso Health Group
A hedge fund recently bought a new stake in Akso Health Group stock. SmartHarvest Portfolios LLC acquired a new stake in shares of Akso Health Group Sponsored ADR (NASDAQ:AHG – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 16,748 shares of the company’s stock, valued at approximately $27,000. 1.21% of the stock is owned by institutional investors.
Akso Health Group Company Profile
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Featured Articles
- Five stocks we like better than Akso Health Group
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
